Lord, Abbett & Co’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-724,625
Closed -$37.1M 541
2024
Q4
$37.1M Sell
724,625
-21,493
-3% -$1.1M 0.12% 219
2024
Q3
$38.1M Sell
746,118
-141,803
-16% -$7.25M 0.12% 205
2024
Q2
$39.8M Sell
887,921
-76,647
-8% -$3.43M 0.13% 206
2024
Q1
$45.2M Buy
964,568
+187,280
+24% +$8.77M 0.15% 192
2023
Q4
$27.7M Buy
+777,288
New +$27.7M 0.1% 272